DK0937100T3 - En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf - Google Patents
En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater derafInfo
- Publication number
- DK0937100T3 DK0937100T3 DK97909496T DK97909496T DK0937100T3 DK 0937100 T3 DK0937100 T3 DK 0937100T3 DK 97909496 T DK97909496 T DK 97909496T DK 97909496 T DK97909496 T DK 97909496T DK 0937100 T3 DK0937100 T3 DK 0937100T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystalline form
- polymorphic crystalline
- fluticasone propionate
- new polymorphic
- preparation
- Prior art date
Links
- 229960000289 fluticasone propionate Drugs 0.000 title abstract 2
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Disintegrating Or Milling (AREA)
- Formation And Processing Of Food Products (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9622173.4A GB9622173D0 (en) | 1996-10-24 | 1996-10-24 | Particulate Products |
PCT/GB1997/002929 WO1998017676A1 (fr) | 1996-10-24 | 1997-10-23 | Nouvelle forme cristalline polymorphe de propionate de fluticasone, son procede de production et des compositions pharmaceutiques la renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0937100T3 true DK0937100T3 (da) | 2003-09-01 |
Family
ID=10801903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97909496T DK0937100T3 (da) | 1996-10-24 | 1997-10-23 | En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US6406718B1 (fr) |
EP (1) | EP0937100B1 (fr) |
JP (1) | JP2001502350A (fr) |
AT (1) | ATE240345T1 (fr) |
AU (1) | AU4717197A (fr) |
CA (1) | CA2269134C (fr) |
DE (1) | DE69722023T2 (fr) |
DK (1) | DK0937100T3 (fr) |
ES (1) | ES2198555T3 (fr) |
GB (1) | GB9622173D0 (fr) |
PE (1) | PE68099A1 (fr) |
PT (1) | PT937100E (fr) |
WO (1) | WO1998017676A1 (fr) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9806462D0 (en) * | 1998-03-26 | 1998-05-27 | Glaxo Group Ltd | Improved compositions for inhalation |
GB9828204D0 (en) * | 1998-12-21 | 1999-02-17 | Smithkline Beecham Plc | Process |
AU782916B2 (en) | 1999-06-09 | 2005-09-08 | Robert E. Sievers | Supercritical fluid-assisted nebulization and bubble drying |
US20020133032A1 (en) * | 2000-02-25 | 2002-09-19 | Jufang Barkalow | Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
EA005992B1 (ru) | 2000-08-05 | 2005-08-25 | Глаксо Груп Лимитед | S-ФТОРМЕТИЛОВЫЙ ЭФИР 6α,9α-ДИФТОР-17α-[(2-ФУРАНИЛКАРБОНИЛ)ОКСИ]-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОКИСЛОТЫ В КАЧЕСТВЕ ПРОТИВОВОСПАЛИТЕЛЬНОГО АГЕНТА |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
GB0021927D0 (en) * | 2000-09-07 | 2000-10-25 | Glaxo Group Ltd | Use of pharmaceutical combination |
GB0027357D0 (en) | 2000-11-09 | 2000-12-27 | Bradford Particle Design Plc | Particle formation methods and their products |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
GB0208742D0 (en) * | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
KR20050035146A (ko) * | 2001-10-10 | 2005-04-15 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 가압 기체성 유체를 사용하는 분말 가공 |
GB0125604D0 (en) * | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
GB0202564D0 (en) * | 2002-02-04 | 2002-03-20 | Glaxo Group Ltd | Process |
ATE464880T1 (de) | 2002-02-04 | 2010-05-15 | Elan Pharma Int Ltd | Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
US20040208833A1 (en) * | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
CA2524773C (fr) | 2003-05-08 | 2014-04-08 | Nektar Therapeutics Uk Ltd | Coformulations particulaires de substances actives comprenant des excipients |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20060009435A1 (en) * | 2004-06-23 | 2006-01-12 | Joseph Kaspi | Synthesis and powder preparation of fluticasone propionate |
EP1904219A4 (fr) | 2005-07-15 | 2011-07-27 | Map Pharmaceuticals Inc | Procede de formation de particules |
US11311477B2 (en) | 2006-03-07 | 2022-04-26 | Sgn Nanopharma Inc. | Ophthalmic preparations |
WO2007103294A2 (fr) * | 2006-03-07 | 2007-09-13 | Novavax, Inc. | Compositions nano-structurees et leurs procedes de fabrication et d'utilisation |
US10137083B2 (en) | 2006-03-07 | 2018-11-27 | SGN Nanopharma Inc | Ophthalmic preparations |
CA2647073A1 (fr) * | 2006-04-03 | 2007-10-18 | Teva Pharmaceutical Industries Ltd. | Microparticules medicamenteuses |
WO2007134845A2 (fr) * | 2006-05-18 | 2007-11-29 | Synthon B.V. | Composition pharmaceutique d'olanzapine |
US20080138409A1 (en) * | 2006-09-29 | 2008-06-12 | Osinga Niels J | Olanzapine pharmaceutical composition |
GB0702402D0 (en) | 2007-02-08 | 2007-03-21 | Thar Pharmaceuticals Inc | Method of creating crystalline substances |
ES2538082T3 (es) | 2007-02-11 | 2015-06-17 | Map Pharmaceuticals Inc | Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios |
US8088824B2 (en) * | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
JP2010111592A (ja) * | 2008-11-04 | 2010-05-20 | Aska Pharmaceutical Co Ltd | プロピオン酸フルチカゾンを含む局所投与剤 |
EP3167875A1 (fr) | 2009-05-27 | 2017-05-17 | Alkermes Pharma Ireland Limited | Réduction d'agrégation de type paillettes dans des compositions de meloxicam nanoparticulaire |
WO2011146583A2 (fr) | 2010-05-19 | 2011-11-24 | Elan Pharma International Limited | Formulations de cinacalcet nanoparticulaire |
MX350838B (es) | 2011-02-11 | 2017-09-18 | Grain Proc Corporation * | Composicion de sal. |
KR20140048237A (ko) * | 2011-07-08 | 2014-04-23 | 화이자 리미티드 | 플루티카손 프로피오네이트 형태 1의 제조 방법 |
IL293779B2 (en) * | 2012-01-13 | 2023-09-01 | Xspray Microparticles Ab | A pharmaceutical preparation containing stable amorphous hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
BR112014027681B8 (pt) | 2012-05-08 | 2023-10-31 | Aciex Therapeutics Inc | Nanocristais de propionato de fluticasona, composição tópica farmacêutica compreendendo os mesmos, seu uso e método de fabricação |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
CN104004044A (zh) * | 2013-02-25 | 2014-08-27 | 武汉诺安药业有限公司 | 高纯度丙酸氟替卡松制备方法 |
CN112494492B (zh) | 2014-08-18 | 2023-08-25 | 阿尔科姆斯制药爱尔兰有限公司 | 阿立哌唑前体药物组合物 |
US10016415B2 (en) | 2014-08-18 | 2018-07-10 | Alkermes Pharma Ireland Limited | Aripiprazole prodrug compositions |
CN108066329B (zh) * | 2016-11-11 | 2021-11-16 | 江苏恒瑞医药股份有限公司 | 一种吸入用氟替卡松或其衍生物的微粒的制备方法 |
WO2021219230A1 (fr) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Traitement antiviral |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1201114A (fr) * | 1980-02-15 | 1986-02-25 | Gordon H. Phillipps | Carbothioates d'androstane |
CY1291A (en) | 1980-02-15 | 1985-10-18 | Glaxo Group Ltd | Androstane 17 beta carbothioates |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
-
1996
- 1996-10-24 GB GBGB9622173.4A patent/GB9622173D0/en active Pending
-
1997
- 1997-10-23 PT PT97909496T patent/PT937100E/pt unknown
- 1997-10-23 CA CA002269134A patent/CA2269134C/fr not_active Expired - Fee Related
- 1997-10-23 DE DE69722023T patent/DE69722023T2/de not_active Expired - Lifetime
- 1997-10-23 US US09/284,245 patent/US6406718B1/en not_active Expired - Fee Related
- 1997-10-23 WO PCT/GB1997/002929 patent/WO1998017676A1/fr active IP Right Grant
- 1997-10-23 AT AT97909496T patent/ATE240345T1/de not_active IP Right Cessation
- 1997-10-23 DK DK97909496T patent/DK0937100T3/da active
- 1997-10-23 JP JP10519130A patent/JP2001502350A/ja not_active Withdrawn
- 1997-10-23 ES ES97909496T patent/ES2198555T3/es not_active Expired - Lifetime
- 1997-10-23 EP EP97909496A patent/EP0937100B1/fr not_active Expired - Lifetime
- 1997-10-23 AU AU47171/97A patent/AU4717197A/en not_active Abandoned
-
1998
- 1998-04-28 PE PE1998000323A patent/PE68099A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6406718B1 (en) | 2002-06-18 |
GB9622173D0 (en) | 1996-12-18 |
DE69722023T2 (de) | 2004-04-08 |
AU4717197A (en) | 1998-05-15 |
JP2001502350A (ja) | 2001-02-20 |
PE68099A1 (es) | 1999-07-19 |
DE69722023D1 (de) | 2003-06-18 |
ES2198555T3 (es) | 2004-02-01 |
WO1998017676A1 (fr) | 1998-04-30 |
EP0937100A1 (fr) | 1999-08-25 |
PT937100E (pt) | 2003-09-30 |
ATE240345T1 (de) | 2003-05-15 |
CA2269134A1 (fr) | 1998-04-30 |
CA2269134C (fr) | 2007-01-09 |
EP0937100B1 (fr) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0937100T3 (da) | En ny polymorfisk krystallinsk form af fluticasonpropionat, fremgangsmåder til fremstilling deraf og farmaceutiske præparater deraf | |
IS5500A (is) | Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum | |
NO993847D0 (no) | Fremgangsmåter og sammensetninger for behandling av allergisk astma og andre sykdommer som anvender deskarboetoksyloratadin | |
DE60117615D1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
NO20002835D0 (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
DE59611189D1 (de) | Vp-antigene des jc-virus | |
NO972972L (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
NO994613D0 (no) | Fremgangsmaate og preparat til behandling av sövn-apne | |
KR970704430A (ko) | 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity) | |
FI972697A0 (fi) | Inhalaatiolaite, menetelmä farmaseuttisesti vaikuttavan aineen dispergoimiseksi ja menetelmä farmaseuttisesti vaikuttavan aineen annoksen jakamiseksi | |
IS2788B (is) | Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar | |
EP0907369A4 (fr) | Materiaux et procedes de traitement de maladies en plaques | |
IS5409A (is) | Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau | |
EP0755372A4 (fr) | Inhibiteurs de la neuraminidase du virus de la grippe et ses methodes de preparation et d'utilisation | |
PL339735A1 (en) | Pappiloma virus capsomer vaccine compositions and methods of applying them | |
NO20010277D0 (no) | Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
IS1571B (is) | Aðferð til framleiðslu á afleiðum tetralíns, cromans og skyldra efnasambanda til meðferðar á asma, liðagigt og skyldum sjúkdómum | |
IT9048261A0 (it) | Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione. | |
AU3703900A (en) | Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders | |
NO983465L (no) | Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser | |
MY117918A (en) | Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps | |
IL127304A (en) | Indoline derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating anxiety and depression | |
HU9203496D0 (en) | Aza-benzimidazoles applicqbles for treatment of asthma, arthritis and similqr diseases |